Synapse - Rikke Baek Holmgaard

Rikke Baek Holmgaard

Research Focus

Former Employee. Human Oncology and Pathogenesis Program; Research Associate

Recent additions – View all

AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity
Meeting Abstract

Chand, D.; Savitsky, D.; Gonzalez, A.; Clarke, C.; Schuster, A.; Drouin, E. E.; Waight, J. D.; Mundt, C.; Ritter, G.; Merghoub, T.; more...
Journal for ImmunoTherapy of Cancer (2017)

Fulltext@MSK | Save
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
Journal Article

Zamarin, D.; Holmgaard, R. B.; Ricca, J.; Plitt, T.; Palese, P.; Sharma, P.; Merghoub, T.; Wolchok, J. D.; Allison, J. P.
Nature Communications (2017)

Fulltext@MSK | Save
Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
Journal Article

Holmgaard, R. B.; Brachfeld, A.; Gasmi, B.; Jones, D. R.; Mattar, M.; Doman, T.; Murphy, M.; Schaer, D.; Wolchok, J. D.; Merghoub, T.
OncoImmunology (2016)

Fulltext@MSK | Save

Co-authors at MSK

14

Wolchok
12

Zamarin
9

Merghoub
4

Allison
3

Gasmi
3

Plitt
2

Zappasodi
1

Brachfeld
1

Budhu
1

De Henau
1

Hirschh...
1

Jones
1

Khalil
1

Lesokhin
1

Li
1

Mattar
1

Murphy
1

Ricca
1

Schaer
1

Subudhi

Types of Work

Publications